142
Views
1
CrossRef citations to date
0
Altmetric
Materials

Novel Synthetic Dopamine Analogues: Carbon-13/Nitrogen-15 Isotopic Labeling and Fluorescence Properties

, , , , , & show all
Pages 170-182 | Received 02 Dec 2021, Accepted 07 Feb 2022, Published online: 26 Feb 2022
 

Abstract

Dopamine (DA) and its analogues are compounds of interest in polymer science where their properties provide a multitude of applications. However, in elucidating polydopamine structure, there are ambiguities related to the types of bonds, the structure of monomeric units, their ratio, and influence of synthesis parameters. In order to minimize these variables, isotopic labeling presents an optimal alternative. In the diversification and understanding of these polymers, we aim to investigate analogues that by selective isotopic labeling provide possibilities for structure elucidation both of the polymerized analogues as well as polydopamine. In the present paper we report the synthesis of three new dopamine derivatives, labeled *CL ((Z)-3-(3,4-bis(benzyloxy)phenyl)-2-cyano-2-propenamide) and both labeled and unlabeled DL/*DL (2-aminomethyl-3-(3,4-dihydroxyphenyl)propionamide). The labeled *CL and *DL compounds contain selective 13C and 15N labeling in the alkyl chain. For these new compounds, NMR, FT-IR and fluorescence characterization, including by time-resolved laser spectroscopy, are reported.

Acknowledgement

The authors acknowledge Dr. Ramona Suciu for conducting the steady-state fluorescence spectroscopy.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This study was supported by the Romanian Ministry of Research under Core Program, Project PN19 35 01 02.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.